Retinal Disease Therapeutics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4170326
- 85 Pages
- February 2021
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Retinal Disease Therapeutics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Retinal Disease Therapeutics market segmented into
Macular Degeneration
Diabetic Macular Edema
Diabetic Retinopathy
Retinal Vein Occlusion
Based on the end-use, the global Retinal Disease Therapeutics market classified into
Hospital Pharmacy
Retail Pharmacy
Others
Based on geography, the global Retinal Disease Therapeutics market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Merck
Novartis
Allergan
Roche
Regeneron
Santen
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL RETINAL DISEASE THERAPEUTICS INDUSTRY
2.1 Summary about Retinal Disease Therapeutics Industry
2.2 Retinal Disease Therapeutics Market Trends
2.2.1 Retinal Disease Therapeutics Production & Consumption Trends
2.2.2 Retinal Disease Therapeutics Demand Structure Trends
2.3 Retinal Disease Therapeutics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Macular Degeneration
4.2.2 Diabetic Macular Edema
4.2.3 Diabetic Retinopathy
4.2.4 Retinal Vein Occlusion
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital Pharmacy
4.3.2 Retail Pharmacy
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Macular Degeneration
5.2.2 Diabetic Macular Edema
5.2.3 Diabetic Retinopathy
5.2.4 Retinal Vein Occlusion
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital Pharmacy
5.3.2 Retail Pharmacy
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Macular Degeneration
6.2.2 Diabetic Macular Edema
6.2.3 Diabetic Retinopathy
6.2.4 Retinal Vein Occlusion
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital Pharmacy
6.3.2 Retail Pharmacy
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Macular Degeneration
7.2.2 Diabetic Macular Edema
7.2.3 Diabetic Retinopathy
7.2.4 Retinal Vein Occlusion
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital Pharmacy
7.3.2 Retail Pharmacy
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Macular Degeneration
8.2.2 Diabetic Macular Edema
8.2.3 Diabetic Retinopathy
8.2.4 Retinal Vein Occlusion
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital Pharmacy
8.3.2 Retail Pharmacy
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Macular Degeneration
9.2.2 Diabetic Macular Edema
9.2.3 Diabetic Retinopathy
9.2.4 Retinal Vein Occlusion
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital Pharmacy
9.3.2 Retail Pharmacy
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Merck
10.1.2 Novartis
10.1.3 Allergan
10.1.4 Roche
10.1.5 Regeneron
10.1.6 Santen
10.2 Retinal Disease Therapeutics Sales Date of Major Players (2017-2020e)
10.2.1 Merck
10.2.2 Novartis
10.2.3 Allergan
10.2.4 Roche
10.2.5 Regeneron
10.2.6 Santen
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Retinal Disease Therapeutics Product Type Overview
2.Table Retinal Disease Therapeutics Product Type Market Share List
3.Table Retinal Disease Therapeutics Product Type of Major Players
4.Table Brief Introduction of Merck
5.Table Brief Introduction of Novartis
6.Table Brief Introduction of Allergan
7.Table Brief Introduction of Roche
8.Table Brief Introduction of Regeneron
9.Table Brief Introduction of Santen
10.Table Products & Services of Merck
11.Table Products & Services of Novartis
12.Table Products & Services of Allergan
13.Table Products & Services of Roche
14.Table Products & Services of Regeneron
15.Table Products & Services of Santen
16.Table Market Distribution of Major Players
17.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
18.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
19.Table Global Retinal Disease Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
20.Table Global Retinal Disease Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
21.Table Global Retinal Disease Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
22.Table Global Retinal Disease Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
